Jim Joyce

Jim Joyce

Algemeen Directeur bij SIGYN THERAPEUTICS, INC.

Vermogen: 11 859 $ op 30-06-2026

64 jaar
Health Technology
Consumer Services
Distribution Services

Profiel

Mr. Jim A. Joyce is a Chairman & Chief Executive Officer at Sigyn Therapeutics, Inc. Mr. Joyce was previously employed as a Chief Executive Officer & Director by Reign Resources Corp., an Executive Chairman by Exosome Sciences, Inc., a Chief Executive Officer, Secretary & Director by Aethlon Medical, Inc., a Chairman & Chief Executive Officer by Mission Labs, Inc., a Member by Denver Broncos Team LLC, a Chief Financial Officer by Innovative Health Monitoring LLC, a Chief Executive Officer by James Joyce & Associates, a Principal by London Zurich Securities, Inc., and a Chairman & Chief Executive Officer by Sigyn Therapeutics, Inc. /Old/.
He received his undergraduate degree from the University of Maryland.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
11-04-2025 320.500 ( 19,96% ) 11 859 $ 30-06-2026

Actieve functies van Jim Joyce

BedrijvenFunctieBegin
SIGYN THERAPEUTICS, INC. Algemeen Directeur 19-10-2019

Eerdere bekende functies van Jim Joyce

BedrijvenFunctieEinde
AETHLON MEDICAL, INC. Algemeen Directeur 10-12-2018
Oprichter 01-01-2018
Mission Labs, Inc.
Algemeen Directeur 01-01-1991
Financieel Directeur/CFO -
Corporate Officer/Principal -
Ervaring van Jim Joyce in detail bekijken

Opleiding van Jim Joyce

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

70

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit11

Health Technology

Consumer Services

Consumer Services

James Joyce & Associates

Mission Labs, Inc.

Health Technology

Distribution Services

London Zurich Securities, Inc.

Electronic Technology

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Jim Joyce